相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells
Yan Li et al.
CANCER LETTERS (2021)
miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers
Yulei Wei et al.
BREAST CANCER (2021)
m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells
Liang Hao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells
Chaojie Li et al.
CANCER CELL INTERNATIONAL (2021)
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China Study
Yi-Long Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Luis Paz-Ares et al.
LANCET ONCOLOGY (2021)
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Hu Lei et al.
NATURE COMMUNICATIONS (2021)
Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models
Maofan Zhang et al.
ACTA BIOMATERIALIA (2021)
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
Nicole Mavingire et al.
CANCER LETTERS (2021)
Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2
Dongliang Wang et al.
THERANOSTICS (2021)
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
Jinbeom Heo et al.
EMBO MOLECULAR MEDICINE (2020)
ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway
Nuozhou Wang et al.
CANCER LETTERS (2020)
Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein
Zhen Sun et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer
Chunli Yin et al.
CELLULAR ONCOLOGY (2020)
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4
Janani Panneerselvam et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis
Ting Yu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling
Xuliang Wang et al.
LIFE SCIENCES (2019)
Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma
Takashi Sato et al.
CANCER RESEARCH (2019)
Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma
Akira Ooki et al.
ONCOGENE (2018)
JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling
Abhinav Adhikari et al.
EPIGENETICS & CHROMATIN (2018)
Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
Sheng-Chieh Lin et al.
CANCER RESEARCH (2016)
JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling
Xiong Lei et al.
ONCOTARGET (2016)
JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression
Chang-Liang Su et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation
Serena Sanulli et al.
MOLECULAR CELL (2015)
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway
Marco Lo Iacono et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
JARID2 Is Involved in Transforming Growth Factor-Beta-Induced Epithelial-Mesenchymal Transition of Lung and Colon Cancer Cell Lines
Shoichiro Tange et al.
PLOS ONE (2014)
Jarid2 (Jumonji, AT Rich Interactive Domain 2) Regulates NOTCH1 Expression via Histone Modification in the Developing Heart
Matthew R. Mysliwiec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Jarid2 and PRC2, partners in regulating gene expression
Gang Li et al.
GENES & DEVELOPMENT (2010)
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators
David Landeira et al.
NATURE CELL BIOLOGY (2010)
Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells
Xiaohua Shen et al.
CELL (2009)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
分享论文
